Actively Recruiting
Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)
Led by Dr. Sophie Degrauwe · Updated on 2022-11-16
1000
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Spontaneous coronary artery dissection (SCAD) is a condition that mainly affects young women without typical heart disease risk factors and can lead to serious problems like heart attack or cardiac arrest. Despite advances in diagnosis, SCAD is still not well understood or well studied. This research involves the SwissSCAD registry, a large observational study designed to track the natural course of SCAD, its outcomes, and how it is treated. The study includes two groups: one made up of patients diagnosed with SCAD in the past five years, whose hospital records will be reviewed retrospectively, and another group of patients newly diagnosed with SCAD who will be followed prospectively. Each patient will be informed about the study and given at least one week to decide on participation. The goal is to include 500 patients in each group. Participants will undergo clinical follow-up to monitor safety events such as heart problems at 30 days, 1 year, and 5 years after diagnosis. Researchers will review medical records and outcomes to better understand SCAD's progression and treatment effectiveness. The study is led by Dr. Sophie Degrauwe and participants will be observed over several years to gather important data on safety and health outcomes.
CONDITIONS
Brief Title
Spontaneous Coronary Artery Dissection National Swiss Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject is 18 years of age or older.
- Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years.
- Subject must be willing to sign a Patient Informed Consent (PIC).
You will not qualify if you...
- Patient unwilling or unable to provide informed consent.
- Patients with atherosclerotic or iatrogenic coronary dissection.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - At least 1 week
Participants are screened for eligibility to participate in the trial.
1 contact by phone
Duration - Up to 5 years
Participants who underwent spontaneous coronary artery dissection are observed for safety events over time.
Follow-up contacts at 30 days, 1 year, and 5 years
Trial Site Locations
Total: 1 location
1
Geneva University Hospitals
Geneva, Switzerland, 1205
Actively Recruiting
Research Team
S
Sophie Degrauwe, Dr
V
Veronique Menoni, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here